Orvana Minerals Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5214
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Metals and Mining
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Orvana Minerals Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Orvana Minerals Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Orvana Minerals Corporation (Orvana) is a mining and exploration company. The company is controlled by Fabulosa Mines Limited, which holds 51.9% interest of its common shares. It undertakes the evaluation, development and mining of precious and base metal deposits. The company produces gold, copper and silver. It operates two projects: The EVBC mines comprising the El Valle-Boinas Mine and the Carles Mine with gold-copper-silver deposits located in Asturias, Spain; and Don Mario project in Bolivia. Don Mario assets include Cerro Felix satellite open pit, Las Tojas ore body, Lower Mineralized Zone (LMZ), and Upper Mineralized Zone (UMZ). Orvana is headquartered in Toronto, Ontario, Canada.

Scope

- Detailed information on Orvana Minerals Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Orvana Minerals Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Orvana Minerals Corporation including a breakdown and examination of key business segments
- Intelligence on Orvana Minerals Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Orvana Minerals Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Orvana Minerals Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Orvana Minerals Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Orvana Minerals Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Orvana Minerals Corporation: Company Overview
Orvana Minerals Corporation: Overview and Key Facts
Orvana Minerals Corporation: Overview
Orvana Minerals Corporation: Key Facts
Orvana Minerals Corporation: Key Employees
Orvana Minerals Corporation: Key Employee Biographies
Orvana Minerals Corporation: Major Products and Services
Orvana Minerals Corporation: Company History
Orvana Minerals Corporation: Management Statement
Orvana Minerals Corporation: Locations and Subsidiaries
Orvana Minerals Corporation: Key Competitors
Orvana Minerals Corporation: Company Analysis
Orvana Minerals Corporation: Business Description
Orvana Minerals Corporation: SWOT Analysis
Orvana Minerals Corporation: SWOT Overview
Orvana Minerals Corporation: Strengths
Orvana Minerals Corporation: Weaknesses
Orvana Minerals Corporation: Opportunities
Orvana Minerals Corporation: Threats
Orvana Minerals Corporation: Recent Developments
Orvana Minerals Corporation: News and Events Summary
Orvana Minerals Corporation: Corporate Governance
Orvana Minerals Corporation: Financial Performance
Orvana Minerals Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Orvana Minerals Corporation: Key Facts
Table 2: Orvana Minerals Corporation: Key Employees
Table 3: Orvana Minerals Corporation: Company History
Table 4: Orvana Minerals Corporation: Locations and Subsidiaries
Table 5: Orvana Minerals Corporation: Key Competitors
Table 6: Orvana Minerals Corporation: News and Events Summary
Table 7: Orvana Minerals Corporation: Corporate Governance
Table 8: Orvana Minerals Corporation: Financial Performance
Table 9: Orvana Minerals Corporation: Strategy and Operations

★海外企業調査レポート[Orvana Minerals Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Encompass Health Corporation:企業の戦略・SWOT・財務情報
    Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report Summary Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cyient Ltd (CYIENT):企業の財務・戦略的SWOT分析
    Cyient Ltd (CYIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nestle USA, Inc.:企業の戦略・SWOT・財務情報
    Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Oric Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oric Pharmaceuticals Inc (Oric Pharmaceuticals) is an independent oncology company that focuses to discover and develop drugs for overcoming resistance in cancer. Its lead drug candidate ORIC-101, which is in phase 1 clinical trial, is a small molecule inhibitor of the glucocorticoid recepto …
  • ERI Bancaire SA:企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Modec Inc (6269):企業の財務・戦略的SWOT分析
    Modec Inc (6269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Genalyte Inc-医療機器分野:企業M&A・提携分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析
    Summary Colby Pharmaceutical Company (Colby Pharma) is a biopharma company that focuses on the development of safe and effective small molecule analgesic, anti-inflammatory drug, and immunobiologic products. Its product portfolio includes Oral small molecule analgesics CPC-123 & CPC-111 for post-sur …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Schlumberger Ltd (SLB)-石油・ガス分野:企業M&A・提携分析
    Summary Schlumberger Limited (Schlumberger) is an oilfield services company that provides technology for reservoir characterization, drilling, production, and processing to the oil and gas industry. Schlumberger also supplies the industries with products and services, from exploration through produc …
  • SandRidge Energy Inc (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • Themis Bioscience GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Cellerant Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cellerant Therapeutics Inc (Cellerant) develops novel immunotherapies for oncology and blood-related disorders. Its lead product, CLT-008, is a myeloid progenitor cell therapy which is in Phase 2 clinical development in patients with acute myeloid leukemia (AML). Cellerant develops various c …
  • Crisil Ltd (CRISIL):企業の財務・戦略的SWOT分析
    Summary Crisil Ltd (Crisil), a subsidiary of S&P Global Inc is a financial service provider that offers risk management services. The company provides ratings, research and risk and policy advisory services. It offers services such as credit ratings, business school gradings, real estate star rating …
  • Healx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Healx Ltd (Healx) is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company’s technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. …
  • International Finance Corp:企業の戦略的SWOT分析
    International Finance Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • BOE Technology Group Co Ltd:企業のM&A・事業提携・投資動向
    BOE Technology Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BOE Technology Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆